Welcome to our dedicated page for Oxus Acquisition news (Ticker: OXUSU), a resource for investors and traders seeking the latest updates and insights on Oxus Acquisition stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Oxus Acquisition's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Oxus Acquisition's position in the market.
Oxus Acquisition Corp. (Nasdaq: OXUS) has announced that its Extraordinary General Meeting of shareholders, initially set for February 28, 2023, has been adjourned. The meeting will now resume on March 2, 2023, at 8:30 a.m. ET, hosted virtually. Key agenda items include proposals to extend the deadline for completing a business combination from March 8, 2023, to December 8, 2023, and to allow Class B ordinary shares to convert into Class A shares before a business combination. Shareholders are encouraged to review the Definitive Proxy Statement filed with the SEC on February 10, 2023, for more details.
Borealis Foods Inc. has entered into a definitive business combination agreement with Oxus Acquisition Corp. (Nasdaq: OXUSU), valuing Borealis at a pre-money enterprise value of $150 million. The merger, expected to finalize in Q3 2023, will enable the combined entity to leverage Borealis’ innovative food technology solutions, including the world's first mass-produced plant-based ramen with 20 grams of protein per serving. The transaction is anticipated to enhance market access, particularly in North America and Europe, where Borealis aims to address global food security challenges.
Oxus Acquisition Corp. announced that its underwriters have fully exercised their over-allotment option, leading to the issuance of an additional 2,250,000 units at $10.00 each. This increases the total units issued in the initial public offering to 17,250,000, raising an aggregate of $172,500,000. Each unit consists of one Class A ordinary share and a redeemable warrant for $11.50 per share. The securities will be traded on the Nasdaq under the symbols OXUS and OXUSW.
Oxus Acquisition Corp. announced the closing of its initial public offering, raising $150 million by offering 15,000,000 units at $10.00 each. These units, which consist of one Class A ordinary share and one redeemable warrant, are now trading on the Nasdaq under the symbol 'OXUSU.' Each warrant allows the purchase of one share at $11.50. The company plans to pursue business combinations focusing on energy transition technologies in emerging markets. The underwriters have a 45-day option to buy an additional 2,250,000 units for over-allotments.
Oxus Acquisition Corp. announced the pricing of its initial public offering (IPO) of 15,000,000 units at $10.00 each, set to trade on Nasdaq under the symbol OXUSU from September 3, 2021. Each unit includes one Class A ordinary share and one redeemable warrant, with warrants exercisable for $11.50 per share. The offering is underwritten by EarlyBirdCapital, Inc. and Sova Capital Limited, with a 45-day option for underwriters to purchase an additional 2,250,000 units. The offering is expected to close around September 8, 2021, subject to standard conditions.
